Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer in Consecutive Cases Unselected for Family History

NCT02790944 is registered in ClinicalTrials.gov with Ambry Genetics as lead sponsor.

NCT NCT02790944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02790944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer in Consecutive Cases Unselected for Family History
Lead sponsor
Ambry Genetics
Phase
Observational
Overall status
Completed
Start date
May 4, 2016
Completion date
August 15, 2020
Enrollment
300 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma